Delivery Order SPE2DB24D3014-SPE2DB25FKULT
- Not listed
- The Defense Logistics Agency awarded a $1,859.98 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Briviact 50 mg tablets (60-count packages). This firm fixed-price delivery order represents a non-set-aside, competitively awarded procurement supporting federal medical supply needs. The order is scheduled for completion by August 19, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,320.35 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count supply) on September 26, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.23 for Briviact 100 mg tablets (60-count) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $5,394.54 delivery order to AmerisourceBergen Drug Corp for Briviact 100mg tablets (60 count) on December 4, 2025, with completion expected by December 5, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical product shipment to support federal medical supply needs. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,624.15 to AmerisourceBergen Drug Corp for Briviact 75 mg tablets (60-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,004.05 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count units) on November 18, 2025, with completion expected by November 19, 2025. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order valued at $2,948.70 to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count supply) on March 5, 2025, with completion expected by March 6, 2025. This firm fixed price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a delivery order valued at $3,869.09 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Briviact 50 mg tablets (60-count). This competitively awarded, firm fixed-price contract requires delivery by November 18, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $4,834.48 to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count units) on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The Defense Logistics Agency awarded a delivery order valued at $3,601.40 to AmerisourceBergen Drug Corp for Briviact 50mg tablets (60-count) on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKULTDelivery Order
The Defense Logistics Agency awarded a $1,859.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count) on August 26, 2025, with completion targeted for August 27, 2025. This competitively awarded, non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has been selected to supply this pharmaceutical product to support defense and military healthcare requirements. This delivery order represents one of numerous pharmaceutical product awards under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle valued through December 2026. The IDC enables the contractor to supply an extensive range of pharmaceutical products, medical supplies, brand-name and generic medications, vaccines, and specialized healthcare commodities to support military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations worldwide. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates consistent capability to fulfill competitive federal procurement requirements across multiple therapeutic domains and transaction sizes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/26/25 |